Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Avecho (ASX:AVE) has received a US$3 million (A$4.7 million) payment from pharma heavyweight Sandoz in exchange for the ...

Avecho Biotechnology (ASX: AVE) has received a maiden payment of approximately $4.7 million (US$3m) from international ...

Corient Private Wealth LLC lessened its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) ...

The global tablets and capsules packaging market is poised for significant growth over the next decade. The market size, estimated to be worth USD 5.3 billion in 2025, is expected to reach USD 9.0 ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...

Balancing safety and convenience, innovative stick pack designs offer a patient-centric solution for on-the-go dosage forms.

The government in Nigeria is warning about the health risks of skin lightening, where potent chemicals can thin and damage ...

Collegium Pharmaceutical Inc. is a specialty pharma ... The company has developed and commercialized products used in the treatment of pain and recently acquired a product that treats attention ...

Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time, the product pull covers about 1.48 million ...

OraTech Pharmaceuticals Inc. - A new joint venture ... and commercialization preparations are underway for oral insulin capsule. OraTech expected to receive royalties from sales in China.